precisionmedicineonline20m
Sarepta's DMD Gene Therapy Elevidys Shows Sustained Benefits in Updated Phase III Data
The positive results from the second part of the EMBARK trial contrast with findings from one-year post treatment, which did ...
precisionmedicineonline21h
Innate Pharma Begins Phase I Trial of IPH4502 in Nectin-4-Expressing Solid Tumors
The trial will include patients with non-small cell lung, breast, ovarian, gastric, esophageal, and colorectal cancers.
precisionmedicineonline23h
Eisai, Biogen's Leqembi Receives FDA Approval for Chronic Alzheimer's Maintenance Treatment
With this approval, patients who receive the anti-amyloid drug biweekly for 18 months can then consider switching to a monthly dosing regimen.